These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31471273)

  • 1. HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse Reservoirs.
    De Scheerder MA; Vrancken B; Dellicour S; Schlub T; Lee E; Shao W; Rutsaert S; Verhofstede C; Kerre T; Malfait T; Hemelsoet D; Coppens M; Dhondt A; De Looze D; Vermassen F; Lemey P; Palmer S; Vandekerckhove L
    Cell Host Microbe; 2019 Sep; 26(3):347-358.e7. PubMed ID: 31471273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
    Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
    Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
    Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
    J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
    Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
    PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
    Vibholm LK; Lorenzi JCC; Pai JA; Cohen YZ; Oliveira TY; Barton JP; Garcia Noceda M; Lu CL; Ablanedo-Terrazas Y; Del Rio Estrada PM; Reyes-Teran G; Tolstrup M; Denton PW; Damsgaard T; Søgaard OS; Nussenzweig MC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
    Gianella S; Chaillon A; Chun TW; Sneller MC; Ignacio C; Vargas-Meneses MV; Caballero G; Ellis RJ; Kovacs C; Benko E; Huibner S; Kaul R
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
    Wang X; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.
    Zhang L; Chung C; Hu BS; He T; Guo Y; Kim AJ; Skulsky E; Jin X; Hurley A; Ramratnam B; Markowitz M; Ho DD
    J Clin Invest; 2000 Oct; 106(7):839-45. PubMed ID: 11018071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.
    Capoferri AA; Redd AD; Gocke CD; Clark LR; Quinn TC; Ambinder RF; Durand CM
    J Acquir Immune Defic Syndr; 2022 Mar; 89(3):297-302. PubMed ID: 34753870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
    Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies.
    Kreider EF; Bar KJ
    Curr HIV/AIDS Rep; 2022 Jun; 19(3):194-206. PubMed ID: 35404007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
    Lee E; von Stockenstrom S; Morcilla V; Odevall L; Hiener B; Shao W; Hartogensis W; Bacchetti P; Milush J; Liegler T; Sinclair E; Hatano H; Hoh R; Somsouk M; Hunt P; Boritz E; Douek D; Fromentin R; Chomont N; Deeks SG; Hecht FM; Palmer S
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31723024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of Plasma HIV Rebound in the Era of Modern Antiretroviral Therapy.
    Sneller MC; Huiting ED; Clarridge KE; Seamon C; Blazkova J; Justement JS; Shi V; Whitehead EJ; Schneck RF; Proschan M; Moir S; Fauci AS; Chun TW
    J Infect Dis; 2020 Oct; 222(10):1655-1659. PubMed ID: 32443148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
    PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.
    Cadena AM; Ventura JD; Abbink P; Borducchi EN; Tuyishime H; Mercado NB; Walker-Sperling V; Siamatu M; Liu PT; Chandrashekar A; Nkolola JP; McMahan K; Kordana N; Hamza V; Bondzie EA; Fray E; Kumar M; Fischinger S; Shin SA; Lewis MG; Siliciano RF; Alter G; Barouch DH
    Nat Commun; 2021 Mar; 12(1):1474. PubMed ID: 33674572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Joseph SB; Kincer LP; Bowman NM; Evans C; Vinikoor MJ; Lippincott CK; Gisslén M; Spudich S; Menezes P; Robertson K; Archin N; Kashuba A; Eron JJ; Price RW; Swanstrom R
    Clin Infect Dis; 2019 Sep; 69(8):1345-1352. PubMed ID: 30561541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
    Palich R; Ghosn J; Chaillon A; Boilet V; Nere ML; Chaix ML; Delobel P; Molina JM; Lucht F; Bouchaud O; Rieux V; Thiebaut R; Levy Y; Delaugerre C; Lelievre JD;
    AIDS; 2019 Feb; 33(2):279-284. PubMed ID: 30325777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective.
    Aid M; Dupuy FP; Moysi E; Moir S; Haddad EK; Estes JD; Sekaly RP; Petrovas C; Ribeiro SP
    Front Immunol; 2018; 9():895. PubMed ID: 29967602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.